- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Polynovo Ltd (PNV)
The Polynovo share price today is 1.005, view ASX PNV stock exchange data. Track the latest Polynovo share price with real-time updates on PNV stock performance including market cap, day range, 52-week range and dividend yield. Access PNV charts, earnings dates and analyst estimates to support your investment decisions.
1.005
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.975
1.025
52 wk Range
0.810
1.660
PNV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.9751.025
52 wk Range
0.8101.660
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PNV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
1.297
Upside
+29.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Cash flows can sufficiently cover interest payments
Calzada receives Investment Bank Analyst Rating Update- Investing.com
Pro
Calzada receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Calzada receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Calzada receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1.297
(+29.09% Upside)
Polynovo Ltd Earnings Call Summary for H2/2026
- PolyNovo reported FY 2026 sales of AUD 138M (up 16.7% reported, 21.3% constant currency) with adjusted EBITDA rising 50% to AUD 13.4M.
- U.S. sales reached AUD 102M with 200 new hospital accounts added; NovoSorb MTX sales nearly doubled to AUD 12.6M from AUD 6.7M prior year.
- Operating cash flow surged to AUD 23.1M from AUD 3.1M; gross margin held at 89%, expected to remain 90-95% until new facility impacts margins.
- Company targets PMA submission by end of calendar 2027 with 12-month FDA review expected; SynPath U.S. launch planned for FY 2027 with HCPCS code secured.
- Shares fell 8% to $0.975 despite strong results, reflecting investor concerns about execution risk, lumpy burn demand, and competitive pressures in wound care.
Last Updated: 26-08-2026, 07:14 am
Read Full TranscriptEarnings
Latest Release
25-08-2026
EPS / Forecast
0.01 / --
Revenue / Forecast
79.52M / 83M
Compare PNV to Peers and Sector
Metrics to compare | PNV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPNVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 95.5x | −2.3x | −0.4x | |
PEG Ratio | −2.15 | 0.05 | 0.00 | |
Price/Book | 7.7x | 2.1x | 2.6x | |
Price / LTM Sales | 4.7x | 1.7x | 3.1x | |
Upside (Analyst Target) | 18.9% | 98.7% | 49.0% | |
Fair Value Upside | Unlock | 25.1% | 7.0% | Unlock |
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Polynovo (PNV) Share Price Today?
The Polynovo share price today is 1.005.
What is the current Polynovo (PNV) share price and day range?
As of 02-09-2026, the Polynovo share price is 1.005, with a previous close of 1.005. The share price has ranged from 0.975 to 1.025 today, while the 52-week range spans from 0.810 to 1.660.
What Is the Polynovo Market Cap?
As of today, Polynovo market cap is 697.750M.
What Is the Polynovo (PNV) Share Price Target?
The average 12-month share price target for Polynovo is 1.297, with a high estimate of 2.1 and a low estimate of 0.95. 6 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +29.09% Upside potential.
What Is Polynovo's Earnings Per Share (TTM)?
The Polynovo EPS (TTM) is 0.011.
When Is the Next Polynovo Earnings Date?
Polynovo will release its next earnings report on 21-08-2026.
From a Technical Analysis Perspective, Is PNV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does Polynovo Trade On?
Polynovo is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Polynovo?
The stock symbol for Polynovo is "PNV."
How Many Times Has Polynovo Stock Split?
Polynovo has split 0 times.
How Many Employees Does Polynovo Have?
Polynovo has 301 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.